Cargando…

Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer

Detalles Bibliográficos
Autores principales: Chen, Yu, Zhou, Zhi-feng, Zhu, Wei-feng, Chen, Gang, Shi, Yi, Lin, Wan-song, Guo, Zeng-qing, Ye, Yun-bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645555/
http://dx.doi.org/10.1186/2051-1426-3-S2-P61
_version_ 1782400839107739648
author Chen, Yu
Zhou, Zhi-feng
Zhu, Wei-feng
Chen, Gang
Shi, Yi
Lin, Wan-song
Guo, Zeng-qing
Ye, Yun-bin
author_facet Chen, Yu
Zhou, Zhi-feng
Zhu, Wei-feng
Chen, Gang
Shi, Yi
Lin, Wan-song
Guo, Zeng-qing
Ye, Yun-bin
author_sort Chen, Yu
collection PubMed
description
format Online
Article
Text
id pubmed-4645555
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46455552015-11-20 Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer Chen, Yu Zhou, Zhi-feng Zhu, Wei-feng Chen, Gang Shi, Yi Lin, Wan-song Guo, Zeng-qing Ye, Yun-bin J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645555/ http://dx.doi.org/10.1186/2051-1426-3-S2-P61 Text en Copyright © 2015 Chen et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Chen, Yu
Zhou, Zhi-feng
Zhu, Wei-feng
Chen, Gang
Shi, Yi
Lin, Wan-song
Guo, Zeng-qing
Ye, Yun-bin
Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title_full Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title_fullStr Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title_full_unstemmed Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title_short Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
title_sort tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645555/
http://dx.doi.org/10.1186/2051-1426-3-S2-P61
work_keys_str_mv AT chenyu tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT zhouzhifeng tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT zhuweifeng tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT chengang tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT shiyi tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT linwansong tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT guozengqing tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer
AT yeyunbin tumormicastatuspredictstheefficacyofimmunotherapywithcytokineinducedkillercellsforpatientswithgastriccancer